Latest filing published 14 May 2026 for DMC Global Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Michael Aaron Kelly span 4 companies, the busiest being DMC Global Inc., Amicus Therapeutics, Inc. and Neogenomics Inc. We count 19 filings; the first trade dates from 12 May 2021 and the latest from 13 May 2026.
The open-market record is one-sided, with 1 purchase worth €34k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 15 share grants and 2 option exercises.
The latest filing, published on 14 May 2026, reports a share grant in DMC Global Inc. The latest purchase dates back some time: it was published 508 days ago, on 28 May 2025. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations